Advertisement

Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems

      Introduction

      Racial/ethnic disparities in colorectal cancer (CRC) screening and diagnostic testing present challenges to CRC prevention programs. Thus, it is important to understand how differences in CRC screening approaches between healthcare systems are associated with racial/ethnic disparities.

      Methods

      This was a retrospective cohort study of patients aged 50–75 years who were members of the Population-based Research Optimizing Screening Through Personalized Regimens cohort from 2010 to 2012. Data on race/ethnicity, CRC screening, and diagnostic testing came from medical records. Data collection occurred in 2014 and analysis in 2015. Logistic regression models were used to calculate AORs and 95% CIs comparing completion of CRC screening between racial/ethnic groups. Analyses were stratified by healthcare system to assess differences between systems.

      Results

      There were 1,746,714 participants across four healthcare systems. Compared with non-Hispanic whites (whites), odds of completing CRC screening were lower for non-Hispanic blacks (blacks) in healthcare systems with high screening rates (AOR=0.86, 95% CI=0.84, 0.88) but similar between blacks and whites in systems with lower screening rates (AOR=1.01, 95% CI=0.93, 1.09). Compared with whites, American Indian/Alaskan Natives had lower odds of completing CRC screening across all healthcare systems (AOR=0.76, 95% CI=0.72, 0.81). Hispanics had similar odds of CRC screening (AOR=0.99, 95% CI=0.98, 1.00) and Asian/Pacific Islanders had higher odds of CRC screening (AOR=1.16, 95% CI=1.15, 1.18) versus whites.

      Conclusions

      Racial/ethnic differences in CRC screening vary across healthcare systems, particularly for blacks, and may be more pronounced in systems with intensive CRC screening approaches.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mandel J.S.
        • Bond J.H.
        • Church T.R.
        • et al.
        Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.
        N Engl J Med. 1993; 328: 1365-1371https://doi.org/10.1056/NEJM199305133281901
        • Schoen R.E.
        • Pinsky P.F.
        • Weissfeld J.L.
        • et al.
        Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.
        N Engl J Med. 2012; 366: 2345-2357https://doi.org/10.1056/NEJMoa1114635
        • Nishihara R.
        • Wu K.
        • Lochhead P.
        • et al.
        Long-term colorectal-cancer incidence and mortality after lower endoscopy.
        N Engl J Med. 2013; 369: 1095-1105https://doi.org/10.1056/NEJMoa1301969
        • Screening for colorectal cancer: U.S.
        Preventive Services Task Force recommendation statement.
        Ann Intern Med. 2008; 149: 627-637https://doi.org/10.7326/0003-4819-149-9-200811040-00243
        • Doubeni C.A.
        • Weinmann S.
        • Adams K.
        • et al.
        Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study.
        Ann Intern Med. 2013; 158(5): 312-320https://doi.org/10.7326/0003-4819-158-5-201303050-00003
        • Hardcastle J.D.
        • Chamberlain J.O.
        • Robinson M.H.
        • et al.
        Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
        Lancet. 1996; 348: 1472-1477https://doi.org/10.1016/S0140-6736(96)03386-7
        • Atkin W.S.
        • Edwards R.
        • Kralj-Hans I.
        • et al.
        Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.
        Lancet. 2010; 375: 1624-1633https://doi.org/10.1016/S0140-6736(10)60551-X
        • Mandel J.S.
        • Church T.R.
        • Bond J.H.
        • et al.
        The effect of fecal occult-blood screening on the incidence of colorectal cancer.
        N Engl J Med. 2000; 343: 1603-1607https://doi.org/10.1056/NEJM200011303432203
        • Kronborg O.
        • Fenger C.
        • Olsen J.
        • Jorgensen O.D.
        • Sondergaard O.
        Randomised study of screening for colorectal cancer with faecal-occult-blood test.
        Lancet. 1996; 348: 1467-1471https://doi.org/10.1016/S0140-6736(96)03430-7
        • Robbins A.S.
        • Siegel R.L.
        • Jemal A.
        Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008.
        J Clin Oncol. 2012; 30: 401-405https://doi.org/10.1200/JCO.2011.37.5527
        • Soneji S.
        • Iyer S.S.
        • Armstrong K.
        • Asch D.A.
        Racial disparities in stage-specific colorectal cancer mortality: 1960-2005.
        Am J Public Health. 2010; 100: 1912-1916https://doi.org/10.2105/AJPH.2009.184192
        • Cooper G.S.
        • Koroukian S.M.
        Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries.
        Cancer. 2004; 100: 418-424https://doi.org/10.1002/cncr.20014
        • Doubeni C.A.
        • Laiyemo A.O.
        • Reed G.
        • Field T.S.
        • Fletcher R.H.
        Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005.
        Cancer Epidemiol Biomarkers Prev. 2009; 18: 2170-2175https://doi.org/10.1158/1055-9965.EPI-09-0104
        • Doubeni C.A.
        • Field T.S.
        • Buist D.S.
        • et al.
        Racial differences in tumor stage and survival for colorectal cancer in an insured population.
        Cancer. 2007; 109: 612-620https://doi.org/10.1002/cncr.22437
        • Laiyemo A.O.
        • Doubeni C.
        • Pinsky P.F.
        • et al.
        Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities.
        J Natl Cancer Inst. 2010; 102: 538-546https://doi.org/10.1093/jnci/djq068
        • Siegel R.
        • Desantis C.
        • Jemal A.
        Colorectal cancer statistics, 2014.
        CA Cancer J Clin. 2014; 64: 104-117https://doi.org/10.3322/caac.21220
        • Vernon S.W.
        Participation in colorectal cancer screening: a review.
        J Natl Cancer Inst. 1997; 89: 1406-1422https://doi.org/10.1093/jnci/89.19.1406
        • Levin T.R.
        • Jamieson L.
        • Burley D.A.
        • Reyes J.
        • Oehrli M.
        • Caldwell C.
        Organized colorectal cancer screening in integrated health care systems.
        Epidemiol Rev. 2011; 33: 101-110https://doi.org/10.1093/epirev/mxr007
        • Doubeni C.A.
        The impact of colorectal cancer screening on the U.S. population: is it time to celebrate?.
        Cancer. 2014; 120: 2810-2813https://doi.org/10.1002/cncr.28789
        • Gupta S.
        • Halm E.A.
        • Rockey D.C.
        • et al.
        Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
        JAMA Intern Med. 2013; 173: 1725-1732https://doi.org/10.1001/jamainternmed.2013.9294
        • Benson V.S.
        • Patnick J.
        • Davies A.K.
        • Nadel M.R.
        • Smith R.A.
        • Atkin W.S.
        Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.
        Int J Cancer. 2008; 122: 1357-1367https://doi.org/10.1002/ijc.23273
        • von Wagner C.
        • Baio G.
        • Raine R.
        • et al.
        Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
        Int J Epidemiol. 2011; 40: 712-718https://doi.org/10.1093/ije/dyr008
        • Blom J.
        • Kilpelainen S.
        • Hultcrantz R.
        • Tornberg S.
        Five-year experience of organized colorectal cancer screening in a Swedish population—increased compliance with age, female gender, and subsequent screening round.
        J Med Screen. 2014; 21: 144-150https://doi.org/10.1177/0969141314545555
        • Rhoads K.F.
        • Patel M.I.
        • Ma Y.
        • Schmidt L.A.
        How do integrated health care systems address racial and ethnic disparities in colon cancer?.
        J Clin Oncol. 2015; 33: 854-860https://doi.org/10.1200/JCO.2014.56.8642
        • Yano E.M.
        • Soban L.M.
        • Parkerton P.H.
        • Etzioni D.A.
        Primary care practice organization influences colorectal cancer screening performance.
        Health Serv Res. 2007; 42(3): 1130-1149https://doi.org/10.1111/j.1475-6773.2006.00643.x
        • Tiro J.A.
        • Kamineni A.
        • Levin T.R.
        • et al.
        The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium.
        Cancer Epidemiol Biomarkers Prev. 2014; 23: 1147-1158https://doi.org/10.1158/1055-9965.EPI-13-1217
        • Lieberman D.A.
        • Rex D.K.
        • Winawer S.J.
        • et al.
        Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer.
        Gastroenterology. 2012; 143: 844-857https://doi.org/10.1053/j.gastro.2012.06.001
      1. University of Washington Rural Health Research Center. Rural-Urban Commuting Area Codes (RUCAa). http://depts.washington.edu/uwruca. Accessed June 19, 2015.

      2. U.S. Department of Agriculture. Rural-urban commuting codes. www.ers.usda.gov/data-products/rural-urban-commuting-area-codes.aspx#.UgUbbm0kAVC. Accessed June 19, 2015.

        • Seaman S.R.
        • White I.R.
        Review of inverse probability weighting for dealing with missing data.
        Stat Methods Med Res. 2013; 22: 278-295https://doi.org/10.1177/0962280210395740
        • Horvitz D.G.
        • Thompson D.J.
        A generalization of sampling without replacement from a finite universe.
        J Am Stat Assoc. 1952; 47: 663-685https://doi.org/10.1080/01621459.1952.10483446
        • Stimpson J.P.
        • Pagan J.A.
        • Chen L.W.
        Reducing racial and ethnic disparities in colorectal cancer screening is likely to require more than access to care.
        Health Aff (Millwood). 2012; 31: 2747-2754https://doi.org/10.1377/hlthaff.2011.1290
        • Benarroch-Gampel J.
        • Sheffield K.M.
        • Lin Y.L.
        • Kuo Y.F.
        • Goodwin J.S.
        • Riall T.S.
        Colonoscopist and primary care physician supply and disparities in colorectal cancer screening.
        Health Serv Res. 2012; 47(3): 1137-1157https://doi.org/10.1111/j.1475-6773.2011.01355.x
        • Jerant A.F.
        • Fenton J.J.
        • Franks P.
        Determinants of racial/ethnic colorectal cancer screening disparities.
        Arch Intern Med. 2008; 168: 1317-1324https://doi.org/10.1001/archinte.168.12.1317
        • James T.M.
        • Greiner K.A.
        • Ellerbeck E.F.
        • Feng C.
        • Ahluwalia J.S.
        Disparities in colorectal cancer screening: a guideline-based analysis of adherence.
        Ethn Dis. 2006; 16: 228-233
        • Ananthakrishnan A.N.
        • Schellhase K.G.
        • Sparapani R.A.
        • Laud P.W.
        • Neuner J.M.
        Disparities in colon cancer screening in the Medicare population.
        Arch Intern Med. 2007; 167: 258-264https://doi.org/10.1001/archinte.167.3.258
        • Liss D.T.
        • Baker D.W.
        Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.
        Am J Prev Med. 2014; 46: 228-236https://doi.org/10.1016/j.amepre.2013.10.023
        • Rutter C.M.
        • Greenlee R.T.
        • Johnson E.
        • et al.
        Prevalence of colonoscopy before age 50.
        Prev Med. 2015; 72: 126-129https://doi.org/10.1016/j.ypmed.2014.12.028
        • Inadomi J.M.
        • Vijan S.
        • Janz N.K.
        • et al.
        Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
        Arch Intern Med. 2012; 172: 575-582https://doi.org/10.1001/archinternmed.2012.332